Traded Nov 16 – Nov 17, 2026 · largest single transaction ~$207K
Show all 2 transactions
Nov 17, 2026~$64K · 133K sh @ $0.48
DetailsOfficial recordNov 16, 2026~$207K · 440K sh @ $0.47
DetailsOfficial record
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
FLNA · NASDAQ · Pharmaceutical Preparations
Filana Therapeutics (FLNA) · oqro.io/stocks/FLNA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$0.56+0.015 (+2.75%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day, not a live quote
1 routine filing (option exercises, shares withheld for taxes, grants, gifts) is not listed here. Show them
Traded Nov 16 – Nov 17, 2026 · largest single transaction ~$207K
Nov 17, 2026~$64K · 133K sh @ $0.48
DetailsOfficial recordNov 16, 2026~$207K · 440K sh @ $0.47
DetailsOfficial recordInsider buying
3 insiders in a week, 2nd time since 2006Traded Nov 16 · filed 2 days later
Since the trade +19.1% · S&P 500 −3.3% · to Nov 19
Filana Therapeutics's Chief Operating& Legal Officer paid $56K out of pocket for Filana Therapeutics shares. 2 other people at Filana Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
3 insiders in a week, 2nd time since 2006Traded Nov 16 · filed 2 days later
Since the trade +19.1% · S&P 500 −3.3% · to Nov 19
The CFO of Filana Therapeutics paid $8.4K out of pocket for Filana Therapeutics shares. 2 other people at Filana Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Traded Sep 28 – Sep 30, 2026 · largest single transaction ~$186K
Sep 29, 2026~$186K · 207K sh @ $0.90
DetailsOfficial recordInsider buying
Their first buy on recordTraded Nov 24, 2025 · filed 1 day later
A Filana Therapeutics director paid $25K out of pocket for Filana Therapeutics shares. 1 other person at Filana Therapeutics bought some too, in the same month.
Insider buying
Traded Nov 20, 2025 · filed 4 days later
The CEO of Filana Therapeutics paid $414K out of pocket for Filana Therapeutics shares. 1 other person at Filana Therapeutics bought some too, in the same month. Shares held went up 19% with this purchase.
Insider buying
Traded Nov 19, 2025 · filed 1 day later
The CEO of Filana Therapeutics paid $202K out of pocket for Filana Therapeutics shares. 1 other person at Filana Therapeutics bought some too, in the same month. Shares held went up 10% with this purchase.
Traded Sep 18 – Sep 22, 2025 · largest single transaction ~$415K
Sep 22, 2025~$16K · 7,172 sh @ $2.28
DetailsOfficial recordTraded Nov 29, 2024 · largest single transaction ~$231KNot reported under a pre-arranged trading plan
Nov 29, 2024~$231K · 60K sh @ $3.86
DetailsInsider selling
Traded Nov 29, 2024 · filed 4 days laterNot reported under a pre-arranged trading plan
Filana Therapeutics's Chief Medical Officer sold $15K of Filana Therapeutics shares. The filing does not indicate a pre-arranged trading plan.
Sep 30, 2026~$92K · 100K sh @ $0.92
DetailsOfficial recordSep 28, 2026~$78K · 93K sh @ $0.84
DetailsOfficial recordSep 18, 2025~$415K · 185K sh @ $2.24
DetailsOfficial recordSep 19, 2025~$107K · 47K sh @ $2.29
DetailsOfficial recordSep 18, 2025~$12K · 5,400 sh @ $2.13
DetailsOfficial recordSep 19, 2025~$900 · 400 sh @ $2.25
DetailsOfficial recordNov 29, 2024~$7.6K · 2,000 sh @ $3.82
DetailsOfficial record6 open-market purchases and 0 open-market sales by insiders of FLNA between Feb 10, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 5, 2026.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 5, 2026 | None | None | 3 purchases |
| Jul 29, 2026 | None | None | None |
| May 7, 2026 | None | None | None |
| Mar 12, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies